TGTX logo

TG Therapeutics (TGTX) Shareholders equity

annual shareholders equity:

$222.36M+$61.86M(+38.54%)
December 31, 2024

Summary

  • As of today (June 23, 2025), TGTX annual stockholders equity is $222.36 million, with the most recent change of +$61.86 million (+38.54%) on December 31, 2024.
  • During the last 3 years, TGTX annual shareholders equity has fallen by -$14.79 million (-6.24%).
  • TGTX annual shareholders equity is now -57.18% below its all-time high of $519.35 million, reached on December 31, 2020.

Performance

TGTX Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

quarterly shareholders equity:

$237.29M+$14.93M(+6.71%)
March 1, 2025

Summary

  • As of today (June 23, 2025), TGTX quarterly stockholders equity is $237.29 million, with the most recent change of +$14.93 million (+6.71%) on March 1, 2025.
  • Over the past year, TGTX quarterly shareholders equity has increased by +$77.18 million (+48.20%).
  • TGTX quarterly shareholders equity is now -54.31% below its all-time high of $519.35 million, reached on December 31, 2020.

Performance

TGTX quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

TGTX Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+38.5%+48.2%
3 y3 years-6.2%+39.3%
5 y5 years+475.9%+10000.0%

TGTX Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.2%+279.5%at high+765.0%
5 y5-year-57.2%+475.9%-54.3%>+9999.0%
alltimeall time-57.2%+3377.3%-54.3%+1020.0%

TGTX Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$237.29M(+6.7%)
Dec 2024
$222.36M(+38.5%)
$222.36M(+15.7%)
Sep 2024
-
$192.16M(+8.2%)
Jun 2024
-
$177.57M(+10.9%)
Mar 2024
-
$160.11M(-0.2%)
Dec 2023
$160.50M(+174.0%)
$160.50M(-2.6%)
Sep 2023
-
$164.77M(+307.3%)
Jun 2023
-
$40.45M(+47.5%)
Mar 2023
-
$27.43M(-53.2%)
Dec 2022
$58.59M(-75.3%)
$58.59M(-41.7%)
Sep 2022
-
$100.48M(-22.1%)
Jun 2022
-
$129.03M(-24.3%)
Mar 2022
-
$170.39M(-28.2%)
Dec 2021
$237.15M(-54.3%)
$237.15M(-23.9%)
Sep 2021
-
$311.52M(-18.7%)
Jun 2021
-
$383.13M(-14.0%)
Mar 2021
-
$445.29M(-14.3%)
Dec 2020
$519.35M(+1244.9%)
$519.35M(+204.3%)
Sep 2020
-
$170.66M(-12.1%)
Jun 2020
-
$194.23M(<-9900.0%)
Mar 2020
-
-$1.35M(-103.5%)
Dec 2019
$38.62M(+60.7%)
$38.62M(-249.7%)
Sep 2019
-
-$25.79M(-295.3%)
Jun 2019
-
$13.21M(-31.4%)
Mar 2019
-
$19.25M(-19.9%)
Dec 2018
$24.04M(-64.1%)
$24.04M(-66.5%)
Sep 2018
-
$71.74M(-29.2%)
Jun 2018
-
$101.38M(+18.9%)
Mar 2018
-
$85.23M(+27.2%)
Dec 2017
$66.99M(+86.8%)
$66.99M(-15.8%)
Sep 2017
-
$79.55M(+2.0%)
Jun 2017
-
$77.97M(-22.8%)
Mar 2017
-
$101.04M(+181.7%)
Dec 2016
$35.87M(-64.7%)
$35.87M(-36.8%)
Sep 2016
-
$56.75M(-27.9%)
Jun 2016
-
$78.70M(-12.0%)
Mar 2016
-
$89.45M(-11.9%)
Dec 2015
$101.57M(+26.8%)
$101.57M(-12.7%)
Sep 2015
-
$116.31M(+3.0%)
Jun 2015
-
$112.95M(+6.3%)
Mar 2015
-
$106.23M(+32.6%)
Dec 2014
$80.10M(+100.0%)
$80.10M(+19.4%)
Sep 2014
-
$67.08M(+28.8%)
Jun 2014
-
$52.10M(-4.3%)
Mar 2014
-
$54.43M(+35.9%)
Dec 2013
$40.05M(+157.6%)
$40.05M(-10.3%)
Sep 2013
-
$44.64M(+334.4%)
Jun 2013
-
$10.28M(-30.1%)
Mar 2013
-
$14.70M(-5.5%)
Dec 2012
$15.55M(+61.6%)
$15.55M(+65.9%)
Sep 2012
-
$9.37M(-14.9%)
Jun 2012
-
$11.02M(-6.2%)
Mar 2012
-
$11.74M(+22.0%)
Dec 2011
$9.62M(-279.4%)
$9.62M(-3367.0%)
Sep 2011
-
-$294.60K(-86.3%)
Jun 2011
-
-$2.15M(+65.0%)
Mar 2011
-
-$1.30M(-75.7%)
Dec 2010
-$5.36M
-$5.36M(-6.5%)
DateAnnualQuarterly
Sep 2010
-
-$5.74M(-0.8%)
Jun 2010
-
-$5.78M(-23.1%)
Mar 2010
-
-$7.52M(+10.8%)
Dec 2009
-$6.79M(+55.1%)
-$6.79M(+2.1%)
Sep 2009
-
-$6.64M(+5.4%)
Jun 2009
-
-$6.31M(+26.1%)
Mar 2009
-
-$5.00M(+14.3%)
Dec 2008
-$4.38M(+391.1%)
-$4.38M(-8.0%)
Sep 2008
-
-$4.76M(+38.0%)
Jun 2008
-
-$3.45M(+1052.8%)
Mar 2008
-
-$299.00K(-66.4%)
Dec 2007
-$891.10K(-159.2%)
-$891.10K(-257.3%)
Sep 2007
-
$566.60K(-79.4%)
Jun 2007
-
$2.75M(-61.6%)
Mar 2007
-
$7.14M(+374.8%)
Dec 2006
$1.50M(-84.2%)
$1.50M(-61.4%)
Sep 2006
-
$3.90M(-28.7%)
Jun 2006
-
$5.47M(-22.1%)
Mar 2006
-
$7.03M(-26.3%)
Dec 2005
$9.54M(+114.2%)
$9.54M(-15.3%)
Sep 2005
-
$11.26M(+1267.6%)
Jun 2005
-
$823.70K(-73.6%)
Mar 2005
-
$3.12M(-29.9%)
Dec 2004
$4.45M(-34.8%)
$4.45M(-27.6%)
Sep 2004
-
$6.15M(-26.1%)
Jun 2004
-
$8.32M(-9.5%)
Mar 2004
-
$9.20M(+34.6%)
Dec 2003
$6.83M(+971.2%)
$6.83M(-1027.8%)
Sep 2003
-
-$736.50K(-128.9%)
Jun 2003
-
$2.55M(-23.0%)
Mar 2003
-
$3.31M(+419.1%)
Dec 2002
$637.90K(-49.0%)
$637.90K(+1359.7%)
Sep 2002
-
$43.70K(-93.1%)
Jun 2002
-
$630.40K(+7.7%)
Mar 2002
-
$585.40K(-53.2%)
Dec 2001
$1.25M(+151.9%)
$1.25M(-1038.9%)
Sep 2001
-
-$133.10K(-125.5%)
Jun 2001
-
$522.90K(-76.0%)
Mar 2001
-
$2.18M(+338.9%)
Dec 2000
$496.10K(-85.4%)
$496.10K(-75.5%)
Sep 2000
-
$2.03M(-5.1%)
Jun 2000
-
$2.13M(-36.3%)
Mar 2000
-
$3.35M(-1.5%)
Dec 1999
$3.40M(-42.4%)
$3.40M(-15.0%)
Sep 1999
-
$4.00M(-7.0%)
Jun 1999
-
$4.30M(-14.0%)
Mar 1999
-
$5.00M(-15.3%)
Dec 1998
$5.90M(-29.8%)
$5.90M(-16.9%)
Sep 1998
-
$7.10M(-13.4%)
Jun 1998
-
$8.20M(+13.9%)
Mar 1998
-
$7.20M(-14.3%)
Dec 1997
$8.40M(+300.0%)
$8.40M(-15.2%)
Sep 1997
-
$9.90M(+350.0%)
Jun 1997
-
$2.20M(+69.2%)
Mar 1997
-
$1.30M(-38.1%)
Dec 1996
$2.10M
$2.10M(-32.3%)
Sep 1996
-
$3.10M(+24.0%)
Jun 1996
-
$2.50M

FAQ

  • What is TG Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for TG Therapeutics?
  • What is TG Therapeutics annual shareholders equity year-on-year change?
  • What is TG Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for TG Therapeutics?
  • What is TG Therapeutics quarterly shareholders equity year-on-year change?

What is TG Therapeutics annual stockholders equity?

The current annual shareholders equity of TGTX is $222.36M

What is the all time high annual shareholders equity for TG Therapeutics?

TG Therapeutics all-time high annual stockholders equity is $519.35M

What is TG Therapeutics annual shareholders equity year-on-year change?

Over the past year, TGTX annual stockholders equity has changed by +$61.86M (+38.54%)

What is TG Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of TGTX is $237.29M

What is the all time high quarterly shareholders equity for TG Therapeutics?

TG Therapeutics all-time high quarterly stockholders equity is $519.35M

What is TG Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, TGTX quarterly stockholders equity has changed by +$77.18M (+48.20%)
On this page